Taspase1 Facilitates Topoisomerase IIβ-Mediated DNA Double-Strand Breaks Driving Estrogen-Induced Transcription.
Lisa OelschlägerPaul StahlFarnusch KaschaniRoland H StauberShirley K KnauerAstrid HenselPublished in: Cells (2023)
The human protease Taspase1 plays a pivotal role in developmental processes and cancerous diseases by processing critical regulators, such as the leukemia proto-oncoprotein MLL. Despite almost two decades of intense research, Taspase1's biology is, however, still poorly understood, and so far its cellular function was not assigned to a superordinate biological pathway or a specific signaling cascade. Our data, gained by methods such as co-immunoprecipitation, LC-MS/MS and Topoisomerase II DNA cleavage assays, now functionally link Taspase1 and hormone-induced, Topoisomerase IIβ-mediated transient DNA double-strand breaks, leading to active transcription. The specific interaction with Topoisomerase IIα enhances the formation of DNA double-strand breaks that are a key prerequisite for stimulus-driven gene transcription. Moreover, Taspase1 alters the H3K4 epigenetic signature upon estrogen-stimulation by cleaving the chromatin-modifying enzyme MLL. As estrogen-driven transcription and MLL-derived epigenetic labelling are reduced upon Taspase1 siRNA-mediated knockdown, we finally characterize Taspase1 as a multifunctional co-activator of estrogen-stimulated transcription.
Keyphrases
- transcription factor
- circulating tumor
- acute myeloid leukemia
- cell free
- single molecule
- estrogen receptor
- gene expression
- dna methylation
- high glucose
- endothelial cells
- genome wide
- diabetic rats
- dna binding
- circulating tumor cells
- cancer therapy
- protein protein
- high throughput
- bone marrow
- dna damage
- genome wide identification
- electronic health record
- copy number
- inflammatory response
- blood brain barrier
- small molecule
- single cell